Epidemiological Trends in Patients Undergoing Mitral Valve Transcatheter Edge-to-Edge Repair over the Last Decade: Functional vs. Structural Mitral Regurgitation.

epidemiology interventional mitral valve repair mitral regurgitation

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
04 Mar 2022
Historique:
received: 12 02 2022
revised: 26 02 2022
accepted: 03 03 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

We aimed to investigate the demographic, clinical and hemodynamic characteristics of patients who underwent percutaneous mitral valve (MV) repair over the last decade, as well as to determine the potential changes in trends of these parameters among patients with structural and functional MR (SMR and FMR). We analyzed all patients who underwent interventional MV repair in our institution between January 2010 and March 2021. Our study included both SMR and FMR patients. All data were obtained from a local registry. Nine hundred and seventeen patients (357 SMR patients and 563 FMR patients) were involved in this study. We did not find significant differences in demographical, clinical and hemodynamic characteristics among SMR and FMR patients. Left ventricular remodeling and systolic dysfunction were more pronounced in FMR patients. Systemic vascular resistance was the only hemodynamic parameter that differed between SMR and FMR patients; it was higher in SMR group. An evaluation of the trend between the first and last five years of our experience revealed that the number of patients treated with this technique is constantly increasing, but that this is more pronounced in SMR patients. It was also found that the operative risk of SMR and FMR patients was significantly higher in the first five years. Additionally, our results showed change in medical therapy in MR patients over the last decade in terms of increased use of angiotensin II receptor blockers and the introduction of angiotensin receptor II blocker-neprilysin inhibitor. SMR and FMR patients who underwent interventional MV repair have similar clinical and hemodynamic characteristics. The percentage of SMR patients increased more significantly than FMR patients over the last five years.

Identifiants

pubmed: 35268513
pii: jcm11051422
doi: 10.3390/jcm11051422
pmc: PMC8911032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Interact Cardiovasc Thorac Surg. 2012 Mar;14(3):258-62
pubmed: 22184465
JACC Cardiovasc Interv. 2019 Jul 22;12(14):1369-1378
pubmed: 31255562
J Clin Med. 2022 Mar 04;11(5):
pubmed: 35268513
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
Catheter Cardiovasc Interv. 2019 Sep 1;94(3):427-435
pubmed: 30592134
N Engl J Med. 2018 Dec 13;379(24):2307-2318
pubmed: 30280640
JAMA. 2021 Jun 22;325(24):2480-2494
pubmed: 34156404
Cardiol J. 2021;28(2):215-222
pubmed: 31313274
Sci Rep. 2020 Oct 13;10(1):17144
pubmed: 33051585
Circulation. 2013 Mar 5;127(9):1018-27
pubmed: 23378298
N Engl J Med. 2018 Dec 13;379(24):2297-2306
pubmed: 30145927
J Thorac Dis. 2018 Jul;10(7):4156-4168
pubmed: 30174860
J Invasive Cardiol. 2020 Dec;32(12):E313-E320
pubmed: 33035179
Prog Cardiovasc Dis. 2021 Jul-Aug;67:98-104
pubmed: 33812859
J Am Coll Cardiol. 2009 Aug 18;54(8):686-94
pubmed: 19679246
Circ Cardiovasc Imaging. 2018 Feb;11(2):e007171
pubmed: 29449412
Eur Heart J Cardiovasc Imaging. 2013 Jul;14(7):611-44
pubmed: 23733442
Heart. 2018 Feb;104(4):306-312
pubmed: 28663365

Auteurs

Leonhard Schneider (L)

Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.

Nicoleta Nita (N)

Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.

Tilman Dahme (T)

Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.

Sinisa Markovic (S)

Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.

Mirjam Keßler (M)

Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.

Wolfang Rottbauer (W)

Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.

Marijana Tadic (M)

Klinik für Innere Medizin II, Universitätsklinikum Ulm, Albert-Einstein Allee 23, 89081 Ulm, Germany.

Classifications MeSH